黄精多糖对APP转基因小鼠学习记忆能力及海马CA1区超微结构影响的研究
|
摘要
阿尔茨海默病(AD)是一种中枢神经系统退行性变性的疾病,以认知记忆功能受损、行为异常、人格改变为临床表现;以大脑组织中神经纤维缠结、β-淀粉样蛋白沉积,神经元变性凋亡,神经髓鞘松解、血管淀粉样变等为病理特征。AD的患病率随着人口老龄化逐年升高,已成为严重影响人们生存期和生活质量的重要因素。因此,关于痴呆的研究有着非常重要的实际意义。
AD的病因尚未明确,治疗也在不断的探索中,作为“常服有延年益寿的作用”的祖国传统中药黄精,其提取液——黄精多糖(PP)具有抗衰老、增强免疫力等作用。本实验采用不同浓度黄精多糖溶液对APP转基因小鼠灌胃干预,观察黄精多糖对APP转基因小鼠学习记忆能力及其对大脑海马超微结构的影响。探讨黄精多糖对实验性AD的作用机制,以寻求防治疗老年痴呆的新的途径和方法。
目的:探讨黄精多糖对实验性AD的疗效及其作用机理。
方法:以APP转基因小鼠作为研究对象,用不同浓度的黄精多糖溶液连续灌胃45天。采用Morris水迷宫法测试小鼠的主动学习记忆能力;采用透射电镜观察海马超微结构并对其进行体视学分析和统计学方法的分析。
结果:实验结果表明黄精多糖具有以下作用:
1.行为学:治疗组(LDG与HDG)与对照组相比,潜伏期缩短、跨越平台的次数增多,错误次数减少(p＜0.01);不同剂量治疗组之间在潜伏期、跨越平台次数之间也有统计学意义(p＜0.05)
2.海马超微结构:与空白对照组相比:(1).黄精多糖治疗组神经元数目相对较多,变性程度减轻,与黄精多糖治疗剂量相关。(2).治疗组小鼠脑组织水肿、细胞器空泡样变性明显减少(p＜0.01)。(3).治疗组有关线粒体、突触及突触界面结构的体视学参数有明显改善(p＜0.05)。
结论:黄精多糖能改善APP转基因小鼠中枢神经系统超微结构及维护中枢神经系统微环境稳定,减少氧化损伤及炎症反应,保护中枢胆碱能系统,显著改善其学习记忆能力,且具有一定的量效关系。黄精多糖是治疗实验性AD的有效药物。
Alzheimer's disease (AD) is the degeneration of the central nervous system (CNS). It's clinically characterized by impairment of memory & cognition, disordered behavior and changed personality, while Neurofibrillary tangles (NFT) ,βAmyloid protein deposition, Neuronal degeneration or apoptosis, neural sheath solution and vascular amyloidosis in brain tissue are its pathological features. With the aging of the population, AD has become one of the most severe problems, which threaten people's life span and quality of life. So it is of great practical value for us to study the disease.
The cause of AD is unknown, and the treatment of it is still in the process of exploring. Polygona-Polysaccharose (PP) is extracted from Rhizoma Polygonati, which is a traditional Chinese medicine that can lengthen one's life. PP can enhance immunity and anti-aging, and so on. In this experiment, we interfered APP transgenic mice with different concentration of PP, and the purpose is to explore the effects and functions of PP on APP transgenic mice, thus to find a new way to prevent and treat the experimental AD.
Objective: To investigate the effect and function of PP on APP transgenic mice.
Method: Inject different concentrations of PP solution into the mice's stomach for 45 consecutive days. The Morris water maze was adopted to test the ability of the mice's initiative learning ability and memory; Transmission Electron Microscope (TEM) was used to observe the ultrastructure of hippocampus; Stereology was adopted to analyze the ultrastructure index and SPSS13.0 was used to analyze the above-mentioned data.
Result: The results show that PP has the following effects:
1. Ethology: Compared with the blank group, the delitescence of the treated group shortened obviously, the frequency of finding the platform increased, and the frequency of making mistakes decreased (p<0.01). Within the treated group, the group with high concentration PP increased in the frequency of finding the platform, shortened in the delitescence, and decreased in the frequency of making mistakes (p<0.05).
2. Hippocampus' ultrastructure: Compared with the blank group: (1) The number of the neurons in the treated group increased while the degeneration degree of the neurons relieved; (2) Mice's brain tissue edema and vacuoles degeneration decreased obviously in the treated group, there are more obvious effect in the high-dose PP group(p<0.01). The stereology parameters of mitochondria, synapse and synaptic interface structure have improved obviously in the treated group (p<0.05). There are significant differences among the groups with different concentration of PP (p<0.05).
Conclusion: PP can improve APP transgenic mice's central nervous system (CNS) ultrastructure, maintain CNS homeostasis, prevent peroxidation & inflammatory reaction, protect the central cholinergic system, and improve the learning ability and memory. There are dose-effect relationships. PP is an effective prescription for the prevention and therapy of experimental AD.
AD的病因尚未明确,治疗也在不断的探索中,作为“常服有延年益寿的作用”的祖国传统中药黄精,其提取液——黄精多糖(PP)具有抗衰老、增强免疫力等作用。本实验采用不同浓度黄精多糖溶液对APP转基因小鼠灌胃干预,观察黄精多糖对APP转基因小鼠学习记忆能力及其对大脑海马超微结构的影响。探讨黄精多糖对实验性AD的作用机制,以寻求防治疗老年痴呆的新的途径和方法。
目的:探讨黄精多糖对实验性AD的疗效及其作用机理。
方法:以APP转基因小鼠作为研究对象,用不同浓度的黄精多糖溶液连续灌胃45天。采用Morris水迷宫法测试小鼠的主动学习记忆能力;采用透射电镜观察海马超微结构并对其进行体视学分析和统计学方法的分析。
结果:实验结果表明黄精多糖具有以下作用:
1.行为学:治疗组(LDG与HDG)与对照组相比,潜伏期缩短、跨越平台的次数增多,错误次数减少(p＜0.01);不同剂量治疗组之间在潜伏期、跨越平台次数之间也有统计学意义(p＜0.05)
2.海马超微结构:与空白对照组相比:(1).黄精多糖治疗组神经元数目相对较多,变性程度减轻,与黄精多糖治疗剂量相关。(2).治疗组小鼠脑组织水肿、细胞器空泡样变性明显减少(p＜0.01)。(3).治疗组有关线粒体、突触及突触界面结构的体视学参数有明显改善(p＜0.05)。
结论:黄精多糖能改善APP转基因小鼠中枢神经系统超微结构及维护中枢神经系统微环境稳定,减少氧化损伤及炎症反应,保护中枢胆碱能系统,显著改善其学习记忆能力,且具有一定的量效关系。黄精多糖是治疗实验性AD的有效药物。
Alzheimer's disease (AD) is the degeneration of the central nervous system (CNS). It's clinically characterized by impairment of memory & cognition, disordered behavior and changed personality, while Neurofibrillary tangles (NFT) ,βAmyloid protein deposition, Neuronal degeneration or apoptosis, neural sheath solution and vascular amyloidosis in brain tissue are its pathological features. With the aging of the population, AD has become one of the most severe problems, which threaten people's life span and quality of life. So it is of great practical value for us to study the disease.
The cause of AD is unknown, and the treatment of it is still in the process of exploring. Polygona-Polysaccharose (PP) is extracted from Rhizoma Polygonati, which is a traditional Chinese medicine that can lengthen one's life. PP can enhance immunity and anti-aging, and so on. In this experiment, we interfered APP transgenic mice with different concentration of PP, and the purpose is to explore the effects and functions of PP on APP transgenic mice, thus to find a new way to prevent and treat the experimental AD.
Objective: To investigate the effect and function of PP on APP transgenic mice.
Method: Inject different concentrations of PP solution into the mice's stomach for 45 consecutive days. The Morris water maze was adopted to test the ability of the mice's initiative learning ability and memory; Transmission Electron Microscope (TEM) was used to observe the ultrastructure of hippocampus; Stereology was adopted to analyze the ultrastructure index and SPSS13.0 was used to analyze the above-mentioned data.
Result: The results show that PP has the following effects:
1. Ethology: Compared with the blank group, the delitescence of the treated group shortened obviously, the frequency of finding the platform increased, and the frequency of making mistakes decreased (p<0.01). Within the treated group, the group with high concentration PP increased in the frequency of finding the platform, shortened in the delitescence, and decreased in the frequency of making mistakes (p<0.05).
2. Hippocampus' ultrastructure: Compared with the blank group: (1) The number of the neurons in the treated group increased while the degeneration degree of the neurons relieved; (2) Mice's brain tissue edema and vacuoles degeneration decreased obviously in the treated group, there are more obvious effect in the high-dose PP group(p<0.01). The stereology parameters of mitochondria, synapse and synaptic interface structure have improved obviously in the treated group (p<0.05). There are significant differences among the groups with different concentration of PP (p<0.05).
Conclusion: PP can improve APP transgenic mice's central nervous system (CNS) ultrastructure, maintain CNS homeostasis, prevent peroxidation & inflammatory reaction, protect the central cholinergic system, and improve the learning ability and memory. There are dose-effect relationships. PP is an effective prescription for the prevention and therapy of experimental AD.
引文
[1]赵红霞,蒙义文.黄精多糖对果蝇寿命的影响.应用与环境生物报,1995,(1):74-77
[2]张均田.老年痴呆的发病机制及防治药物.医药导报,2002;21(8):469-71.
[3]王建枝,龚成新,Inge GRUND KE-IQBAL,Khalid IQBAL,Dissociation of Alzheimer Paired Helical Filaments by Protein Phosphatases.Chinese Journal of Biochemistry and Molecular Biology,1999,115(1):123-127
[4]Soo Bong CHO and Sunmin PARK ZeBiosci.A Steroidal Glycoside from Polygonatum odoratum(Mill.)Druce.Improves Insulin Resistance but does not Alter Insulin Secretion in 90%Pancreatectomized Rats,Biotechnol.Biochem,66(10),2036-2043,2002
[5]Ali SM,Dunn E,Oostveen JA,et al.Induction of apolipoprotein E,mRNA in the hippocampus of the gerbil after transient global ischemia.Brain Res Mol Brian Res,1996,38:37-44.
[6]He YS,Yao ZB,Ga YM,et al.NGF promotes collateral sprouting of cholinergic fibers in the septohippocampal cholinergic system of aged rats fimbria transaction.Neurosci Lett,1991,129;189-192
[7]Klauck TM,Scott JD.The postsynaptic density:a subcellular anchor for signal transduction enzymes.Cell Signal,1995,7:747-757
[8]郑富盛,细胞形态立体计量学,北京医科大学中国协和医科大学联合出版社,1990;6-21;36-44;86;147-150
[9]吴馥梅,杜红燕,章子贵.突触界面曲率及其生理意义.神经解剖学杂志,1994.10:89-92
[10]Jones DG,Devon RM.An ultrastructural study into the effects of pentobarbitone on synaptic organization.Brain Res,1978,147:47-63
[11]Gundersen HJG.Notes on estimation of the numerical density of arbitrary profiles:the edge effect.Micros,1997;111(2):219
[12]Kennedy MB,The postsynaptic density at glutamatergic synapses.Trends Neurosci,1997,20:264-268
[13]Wilson MA,Tonegawa S.Synaptic plasticity,place cells and spatial memory:study with second-generation knockouts.Trends Neurosci,1997,20:102-106
[14]李亚,吴馥梅.突触后致密结构的可塑性.中国组织化学与细胞化学杂志,1999,8:352-354
[15]宋焱,祁吉,尹建忠.AD大鼠模型的MRI及MR体积测量与病理对照研究.放射学实践,2005,20(9):814-817
[16]陈新谦,金有豫,汤光,等.新编药物学第16版,北京,人民卫生出版社,2007,805-806
[17]汪兴平,莫开菊,周大寨.黄精含硒多糖的分离提取及含硒量分析技术研究,食品科学,2004,25(10):119-122
[18]金英子,曲香芝,张红英.复方黄精对小鼠耐缺氧及抗疲劳能力的影响.Journal of Medical Science Yanbian University Mar 2006;1(29):40-41
[19]毛雁,马兰军,熊正英.黄精对力竭训练大鼠血清酶活性及某些生化指标的影响,第四军医大学学报,2007,28(20):1842-1844
[20]项平.七种中药抗老作用的实验观察.辽宁中医杂志,1982,(3):44-49
[21]赵红霞,蒙义文,曾庆华,黄精多糖对老龄大鼠衰老生理生化指标的影响,应用与环境生物学报,1996,2(4):356-360
[22]薛春苗,任汉阳,薛润苗,黄精粗多糖对温热药致阴虚模型小鼠抗氧化作用的实验研究,河南中医.2006,26(3):24-26
[23]陈金水,陈松苍,王雄华,等。黄精口服液对剧烈运动小鼠氧自由基代谢及血肌酸激酶影响.中国中西医结合杂志1996年基础理论研究特集:258-259
[24]王和生,林亚平,齐敏友,等。黄精首乌有效部分均匀设计组合对高脂血症大鼠抗脂质过氧化的影响,中华中医药杂志,2005;20(8):502-504
[25]李友元,杨宇,等.黄精煎液对衰老小鼠组织端粒酶活性的影响.华中医学杂志,2002;26(4):225-227
[26]李友元,邓洪波,王蓉,等.衰老小鼠组织端粒酶活性变化及黄精多糖的干预作用,医学临床研究,2005;22(7):894-895
[27]吴燊荣,李友元,王小清,等.黄精多糖对脂肪组织分泌的生物活性物质致肝 细胞HepG2分泌C反应蛋白的影响.中华医学杂志,2004(84)17:1447-1448
[28]张萍,刘丹,李友元.黄精多糖对动脉粥样硬化家兔血清IL-6及CRP的影响.医学临床研究2006;23(7):1100-1101
[29]Li You-yuan,Deng Hong-bo,Wang Rong,et al.Regulation of polygonati polysaccharide on expression of glycosylated end-product receptor mRNA in cardiac and renal tissues of diabetic mice,Chinese Journal of Clinical Rehabilitation,2005;9(47):177-179
[30]夏晓凯,张庭廷,陈传平.黄精多糖的体外抗氧化作用研究.湖南中医杂志.2006;22(4):90:91
[31]赵小贞,王玮,康仲涵.黄精口服液对血管性痴呆大鼠学习记忆与海马突触可塑性的影响.神经解剖学杂志.2005;21(2):147-153
[32]张峰,张继国,王丽华,等.黄精多糖对东莨菪碱致小鼠记忆获得障碍的改善作用.现代中西医结合杂志.2007;16(36):5410-5412
[33]文珠,肖移生,唐宁,等.黄精多糖对神经细胞的毒性及抗缺氧性坏死和凋亡作用研究.中药药理与临床.2006;22(2):29-31
[34]Liu Peixun,Gao Xiaorong,Xu Wenqing,et.Study on antioxidation activities of polysaccharides extracted from Tremella fuciformis Berk.中药药理与临床.2005;21(4):37-39
[35]李微,彭锐,唐理斌,滇黄精对大鼠脑缺血再灌注损伤神经元的作用.大理学院学报.2006;5(10):19-21
[36]胡国柱,聂荣庆,肖移生,等.黄精多糖对新生大鼠大脑皮层神经细胞缺氧性凋亡的影响.中国药理与临床;2005;21(4):37-39
[37]Bertram L,Hiltunen M,Parkinson M,et al.Family-based association between Alzheimer's disease and variants in UBQLN.N Engl Med,2005,352:884-894.
[38]Mufosn EJ,Ginsber SD,Ikonomovic MD,et al.Human cholinergic basal forebrain:chemo anatomy and neurologic dysfunction.Chem Neuroanat 2003,26(4):233-242.
[39]Ben Ari Y,Trembley E,Ollergen OP.The role of epileptic activity in hippocampal and remove cerebral lesions induced by bainic acid.Brain Res,1980;(9):79-83
[40] Solroniew MV, Pearson RCA. Degene relation of cholinergic neuron in the basal nuclear fallowing bainic or N-melhyl-D-aspirlic acid application to the cerebral cortex in the rat. Protein Res, 1985; 339(1): 186-9
[41] Xiao Aiwu, Dai Jiapei .Axonal Leakage is a Key Neuropathological Change in Alzheimer's disease. Acta Med Univ Sci Technol Huazhong, Apr.2006; 35(2): 277
[42] Mayo JC, Sainz RM, Antolin I, et al. Ultrastruall confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage . Brain Res, 1999, 818(2): 22-27.
[43] Perkins CL, Fang G, Kim CN, et al.The role of Apat-1, caspase-9, and Bid protein in etoposide or paclilaxel induced mitochondria events during apoptosis. Cancer Res, 2000;60(6):1645-1653.
[44] Howard Y. Microbiology and molecular biology Reviews. American Society for Microbiology, 2000,Dec, 64(4): 829-831.
[45] Misonou H, Morishima Kawashima M, Ihara Y, et al. Oxidative stress induces intracellular accumulation of amyloid beta-protein (A-beta) in human neuroblastoma cells. Biochemistry, 2000,39(23): 6951-6959
[46] Hensley K, Carney J, Mattson M, et al. A model for beta2amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci, 1994, 91 (8): 3270-3274.
[47] Farr SA, Poon HF, Dogrukol-AK D, et al. The antioxidants alphalipoic acid and N-acetylcysteine revels memory impairment and oxidative stressing in aged SAMP8 mice. J Neurochem.2003; 84(5): 1173-1183
[48] Meeocci P. Oxidative stress in mild cognitive impairment and Alzheimer disease: a continuum. J Alzheimer Dis,2004,6(2): 159-163.
[49] Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging, 2000; 21(3): 383-421
[50] McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease a review of 17 epidemiologic studies. Neurology. 1996; 47:425-432.
[1].Ferri CP,Prince M,Brayne C,et al.Global prevalence of dementia:a Delphi consensus study.Lancet,2005,366(9503):2112-2117.
[2].Walsh DM,Klyubin I,Fadeeva J V,et al.Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentination in vivo.Nature,2002,416(6680):535-539
[3].Schenk D,Barbour R,Dunn W.Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.Nature,1999,400(6740):173-177
[4].Bertram L,Hiltunen M,Parkinson M,et al.Family-based association between Alzheimer's disease and variants in UBQLN.N Engl Med,2005,352:884-894.
[5]. Mufosn EJ, Ginsber SD, Ikonomovic MD, et al. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. Chem Neuroanat 2003, 26(4): 233-242.
[6]. DeKosky ST, Ikonomovic MD, Wang X, et al. Plasma and cerebrospinal fluid alphalantichymOtrypsin levels in Alzheimer's disease: correlation with cognitive impairment.Ann Neurol, 2003, 53: 81-90.
[7]. Wen GY, Yang SY, Kaczmarski W, et al. Presence of hydroxysteroid dehydrogenase type 10 in amyloid plaques(APs) of Hsiao's APP-Sw transgenic mouse brains. But absence in Aps of Alzheimer's disease brains .Brain Res. 2002. 954:115-122.
[8]. Lee MS, Kao SC, lemere CA, et al. APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol 2003; 163(1): 83-95
[9]. Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging, 2000, 21(3): 383-421
[10]. McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents are possible protective factors for Alzheimer's disease, a review of 17 epideiologic studies.. Neurology, 1996,47:425-432.
[11]. Hashimoto M, Rockenstein E, Crews L, et al. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and arkinson' s diseases.. NeuromolMed, 2003; 4 (122): 21-36
[12]. Behl C, Davis JB, Lesley R, et al. Hydrogen peroxide mediates amyloidβ protein toxicity. Cell, 1994,77: 817-827.
[13].Hensley K, Carney J, Mattson M, et al. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci, 1994, 91 (8): 3270-3274.
[14]. Lovell MA, Xie C, Markesbery W R.Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimers disease. Neurology, 1998,51:1562-1566.
[15]. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science 2002; 298(5594):789-91
[16].Mayo JC,Sainz RM,Antolin I,et al.Ultrastruall confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage.Brain Res,1999,818(2):22-27.
[17].Perkins CL,Fang G,Kim CN,et al.The role of Apat-1,caspase-9 and Bid protein in etoposide or paclilaxel in-duecd mitochondrial events during apoptosis.Cancer Res,2000,60(6):1645-1653.
[18]Farr SA,Poon HF,Dogrukol-AK D,et al.The antioxidants alphalipoic acid and N-acetylcysteine revelse memory impairment and oxidative stressing in aged SAMP8 mice.J Neurochem,2003,84(5):1173-1183.
[19]Veerendra Kumar MH,Gupta YK.Effect centella assiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats.Clin Exp Pharmacol Physiol,2003,30(5-6):336-342.
[20]Meeocci P.Oxidative stress in mild cognitive impairment and Alzheimer disease:a continuum.J AlzheinmmDis,2004,6(2):159-163.
[21].Nalbamoglu J,Timdo-santago G.Labsaini A,et at.Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein..Nature,1997.387(6632)-500-805
[22].Vina J,Lloret A,Orti R,et al.Molecular bases of the treatment of Alzheimer's disease with antioxidants:prevention of oxidative stress.Mol Aspects Med,2004,25:117-123.
[23]Xiao Aiwu,Dai Jiapei.Axonal Leakage is a Key Neuropathological Change in Alzheimer's disease.Acta Med Univ Sci Technol Huazhong,Apr.2006,vol.35 No.2P277
[24].Walker LC,Kitt CA,Schwam E,et al.Senile plaques in aged squirrel monkeys.Neurobiol Aging.1987,8:291-296
[25].洪岸,姚志彬,顾耀铭,等.老年大鼠学习记忆减退与海马结构的突触素改变,解剖学报,1996,27:164
[26]KumarVB,Vyes K,Frarcko M.Molecular cloning expression and regulation of hippocampal amyboid precursur protein of senescence accelerated mouse(SAMP8).Biocheus Cell Biol,2001;79(1):57-67
[27].Pavia J,AlberchJ,Alvarez I,Toledano A,de Ceballos ML.Repeated administration of beta-amyboid(25-35)to rats decreases muscarinic receptor in cerebral cortex.Neurosci Lett,2000;278(1-2):69-72
[28].Ben Ari Y,Trembley E,Ollergen OP.The role of epileptic activity in hippocampal and remove cerebral lesions induced by bainic acid.Brain Res,1980;(9):79-83
[29].Solroniew MV,Pearson RCA.Degene relation of cholinergic neurone in the basal nuclear fallowing bainic or N-melhyl-D-aspirlic acid application to the cerebral cortex in the rat.Protein Res,1985;339(1):18-19
[30]赵淑梅,左凤英.呆聪液对老龄大鼠痴呆模型免疫功能的影响.淮坊医学院学报,2000;22(1):11-2
[31]张世仪,何利明,张敏磊,等。一种脑损伤所致认知障碍的动物模型。中国康复医学杂志,1993,8(5):196-198
[32]Shang YZ,Cheng JJ,Qi JM,et al.Scutellaria flavonoid reduced memory dysfunction and neuronal injury caused by permanent global ischemia in rats.Pharmacol Biochem & Behav,2005,82:67.
[33]De La.Torry JC.Critically attained threshold of cerebral hypopeffusion:Can it cause Alzheimer's disease.Neurobiol Aging,2000;21(2):32-42
[34]Pappolla MA,Chyan YJ,Poeggeler B.An assessment of the antioxidant and the antiamyloidugenic properties of melatonin:implications for Alzheimer's disease.Neural Transm,2000;107(1):23-31
[35].宋敏,唐军,李达兵,徐海伟,白云,PS1/APP双转基因阿尔茨海默病模型传代小鼠的基因型鉴定及其组织学分析,第三军医大学学报,2006;28(14):1453-1456
[36].Golz J,Probst A,Spillantini MG,et al.Somunto dendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform.EMBO J,1995,14(7)1304-1313
[37].Holtzman DM,Fagan AM,Mackey B,et al.Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.Ann Neurol,2000,47(6):739-74
[38].Van den,Haute C.Spittaels K.Van Dorpe J.et al.Coexpression of human cdk5and its activator p35 with human protein tau in neurons in brain ot triple transgenic mouse.Neurobiol Dis.2001,8:32-34.
[39].Brion JP,Anderton BH,Authelet M,et al.Neurofibrillary tangles and tau phosphorylatlon.Biochem Soc Symp,2001,67:203-210.
[40].Lewis J,Dickson DW,Lin WL,et al.Enhanced Neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.Science,2001.293:148-149
[41].Oddo S,Caccamo A,Kitazawa M,et al.Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.Neurobiol Agin.2003,24:1063-1070.
[42].Iwata N,Tsubuki S,Takaki Y,et al.Metabolic regulation of brain A beta by neprilysin.Science,2001,292:1550-1552
[43].Morimoto K,Yoshimi K,Tonohiro T,et al.The Co-injection of β-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons.Neuroscience,1998,84(2):479.
[44].Nakagawa Y,Nakamura R,Kase K,et al.Colchicine lesions in the rat hippocampus mimic the alterations of several markers in Alzheimer's disease.Brain Res,1987;408(1～2):57-64
[45].Katzmon R.Alzheimer's disease.N Eng J Med,1986,314:964.
[46]李斌,郭德玉,李林.三种老年痴呆动物模型行为学比较.中国实验动物学报,1999,(7):1.
[47].徐海伟,黎海蒂,范晓棠等,AD大鼠模型的制备及行为学和超微结构研究,中国行为医学科学2003,12(2):123-126
[48].王建枝,龚成新,Inge GRUND KE-IQBAL,Khalid IQBAL,Dissociantion of Alzheimer Paired Helical Filaments by Protein Phosphatases.Chinese Journal of Biochemistry and Molecular Biology.Feb,1999,115(1):123-127
[2]张均田.老年痴呆的发病机制及防治药物.医药导报,2002;21(8):469-71.
[3]王建枝,龚成新,Inge GRUND KE-IQBAL,Khalid IQBAL,Dissociation of Alzheimer Paired Helical Filaments by Protein Phosphatases.Chinese Journal of Biochemistry and Molecular Biology,1999,115(1):123-127
[4]Soo Bong CHO and Sunmin PARK ZeBiosci.A Steroidal Glycoside from Polygonatum odoratum(Mill.)Druce.Improves Insulin Resistance but does not Alter Insulin Secretion in 90%Pancreatectomized Rats,Biotechnol.Biochem,66(10),2036-2043,2002
[5]Ali SM,Dunn E,Oostveen JA,et al.Induction of apolipoprotein E,mRNA in the hippocampus of the gerbil after transient global ischemia.Brain Res Mol Brian Res,1996,38:37-44.
[6]He YS,Yao ZB,Ga YM,et al.NGF promotes collateral sprouting of cholinergic fibers in the septohippocampal cholinergic system of aged rats fimbria transaction.Neurosci Lett,1991,129;189-192
[7]Klauck TM,Scott JD.The postsynaptic density:a subcellular anchor for signal transduction enzymes.Cell Signal,1995,7:747-757
[8]郑富盛,细胞形态立体计量学,北京医科大学中国协和医科大学联合出版社,1990;6-21;36-44;86;147-150
[9]吴馥梅,杜红燕,章子贵.突触界面曲率及其生理意义.神经解剖学杂志,1994.10:89-92
[10]Jones DG,Devon RM.An ultrastructural study into the effects of pentobarbitone on synaptic organization.Brain Res,1978,147:47-63
[11]Gundersen HJG.Notes on estimation of the numerical density of arbitrary profiles:the edge effect.Micros,1997;111(2):219
[12]Kennedy MB,The postsynaptic density at glutamatergic synapses.Trends Neurosci,1997,20:264-268
[13]Wilson MA,Tonegawa S.Synaptic plasticity,place cells and spatial memory:study with second-generation knockouts.Trends Neurosci,1997,20:102-106
[14]李亚,吴馥梅.突触后致密结构的可塑性.中国组织化学与细胞化学杂志,1999,8:352-354
[15]宋焱,祁吉,尹建忠.AD大鼠模型的MRI及MR体积测量与病理对照研究.放射学实践,2005,20(9):814-817
[16]陈新谦,金有豫,汤光,等.新编药物学第16版,北京,人民卫生出版社,2007,805-806
[17]汪兴平,莫开菊,周大寨.黄精含硒多糖的分离提取及含硒量分析技术研究,食品科学,2004,25(10):119-122
[18]金英子,曲香芝,张红英.复方黄精对小鼠耐缺氧及抗疲劳能力的影响.Journal of Medical Science Yanbian University Mar 2006;1(29):40-41
[19]毛雁,马兰军,熊正英.黄精对力竭训练大鼠血清酶活性及某些生化指标的影响,第四军医大学学报,2007,28(20):1842-1844
[20]项平.七种中药抗老作用的实验观察.辽宁中医杂志,1982,(3):44-49
[21]赵红霞,蒙义文,曾庆华,黄精多糖对老龄大鼠衰老生理生化指标的影响,应用与环境生物学报,1996,2(4):356-360
[22]薛春苗,任汉阳,薛润苗,黄精粗多糖对温热药致阴虚模型小鼠抗氧化作用的实验研究,河南中医.2006,26(3):24-26
[23]陈金水,陈松苍,王雄华,等。黄精口服液对剧烈运动小鼠氧自由基代谢及血肌酸激酶影响.中国中西医结合杂志1996年基础理论研究特集:258-259
[24]王和生,林亚平,齐敏友,等。黄精首乌有效部分均匀设计组合对高脂血症大鼠抗脂质过氧化的影响,中华中医药杂志,2005;20(8):502-504
[25]李友元,杨宇,等.黄精煎液对衰老小鼠组织端粒酶活性的影响.华中医学杂志,2002;26(4):225-227
[26]李友元,邓洪波,王蓉,等.衰老小鼠组织端粒酶活性变化及黄精多糖的干预作用,医学临床研究,2005;22(7):894-895
[27]吴燊荣,李友元,王小清,等.黄精多糖对脂肪组织分泌的生物活性物质致肝 细胞HepG2分泌C反应蛋白的影响.中华医学杂志,2004(84)17:1447-1448
[28]张萍,刘丹,李友元.黄精多糖对动脉粥样硬化家兔血清IL-6及CRP的影响.医学临床研究2006;23(7):1100-1101
[29]Li You-yuan,Deng Hong-bo,Wang Rong,et al.Regulation of polygonati polysaccharide on expression of glycosylated end-product receptor mRNA in cardiac and renal tissues of diabetic mice,Chinese Journal of Clinical Rehabilitation,2005;9(47):177-179
[30]夏晓凯,张庭廷,陈传平.黄精多糖的体外抗氧化作用研究.湖南中医杂志.2006;22(4):90:91
[31]赵小贞,王玮,康仲涵.黄精口服液对血管性痴呆大鼠学习记忆与海马突触可塑性的影响.神经解剖学杂志.2005;21(2):147-153
[32]张峰,张继国,王丽华,等.黄精多糖对东莨菪碱致小鼠记忆获得障碍的改善作用.现代中西医结合杂志.2007;16(36):5410-5412
[33]文珠,肖移生,唐宁,等.黄精多糖对神经细胞的毒性及抗缺氧性坏死和凋亡作用研究.中药药理与临床.2006;22(2):29-31
[34]Liu Peixun,Gao Xiaorong,Xu Wenqing,et.Study on antioxidation activities of polysaccharides extracted from Tremella fuciformis Berk.中药药理与临床.2005;21(4):37-39
[35]李微,彭锐,唐理斌,滇黄精对大鼠脑缺血再灌注损伤神经元的作用.大理学院学报.2006;5(10):19-21
[36]胡国柱,聂荣庆,肖移生,等.黄精多糖对新生大鼠大脑皮层神经细胞缺氧性凋亡的影响.中国药理与临床;2005;21(4):37-39
[37]Bertram L,Hiltunen M,Parkinson M,et al.Family-based association between Alzheimer's disease and variants in UBQLN.N Engl Med,2005,352:884-894.
[38]Mufosn EJ,Ginsber SD,Ikonomovic MD,et al.Human cholinergic basal forebrain:chemo anatomy and neurologic dysfunction.Chem Neuroanat 2003,26(4):233-242.
[39]Ben Ari Y,Trembley E,Ollergen OP.The role of epileptic activity in hippocampal and remove cerebral lesions induced by bainic acid.Brain Res,1980;(9):79-83
[40] Solroniew MV, Pearson RCA. Degene relation of cholinergic neuron in the basal nuclear fallowing bainic or N-melhyl-D-aspirlic acid application to the cerebral cortex in the rat. Protein Res, 1985; 339(1): 186-9
[41] Xiao Aiwu, Dai Jiapei .Axonal Leakage is a Key Neuropathological Change in Alzheimer's disease. Acta Med Univ Sci Technol Huazhong, Apr.2006; 35(2): 277
[42] Mayo JC, Sainz RM, Antolin I, et al. Ultrastruall confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage . Brain Res, 1999, 818(2): 22-27.
[43] Perkins CL, Fang G, Kim CN, et al.The role of Apat-1, caspase-9, and Bid protein in etoposide or paclilaxel induced mitochondria events during apoptosis. Cancer Res, 2000;60(6):1645-1653.
[44] Howard Y. Microbiology and molecular biology Reviews. American Society for Microbiology, 2000,Dec, 64(4): 829-831.
[45] Misonou H, Morishima Kawashima M, Ihara Y, et al. Oxidative stress induces intracellular accumulation of amyloid beta-protein (A-beta) in human neuroblastoma cells. Biochemistry, 2000,39(23): 6951-6959
[46] Hensley K, Carney J, Mattson M, et al. A model for beta2amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci, 1994, 91 (8): 3270-3274.
[47] Farr SA, Poon HF, Dogrukol-AK D, et al. The antioxidants alphalipoic acid and N-acetylcysteine revels memory impairment and oxidative stressing in aged SAMP8 mice. J Neurochem.2003; 84(5): 1173-1183
[48] Meeocci P. Oxidative stress in mild cognitive impairment and Alzheimer disease: a continuum. J Alzheimer Dis,2004,6(2): 159-163.
[49] Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging, 2000; 21(3): 383-421
[50] McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease a review of 17 epidemiologic studies. Neurology. 1996; 47:425-432.
[1].Ferri CP,Prince M,Brayne C,et al.Global prevalence of dementia:a Delphi consensus study.Lancet,2005,366(9503):2112-2117.
[2].Walsh DM,Klyubin I,Fadeeva J V,et al.Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentination in vivo.Nature,2002,416(6680):535-539
[3].Schenk D,Barbour R,Dunn W.Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.Nature,1999,400(6740):173-177
[4].Bertram L,Hiltunen M,Parkinson M,et al.Family-based association between Alzheimer's disease and variants in UBQLN.N Engl Med,2005,352:884-894.
[5]. Mufosn EJ, Ginsber SD, Ikonomovic MD, et al. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. Chem Neuroanat 2003, 26(4): 233-242.
[6]. DeKosky ST, Ikonomovic MD, Wang X, et al. Plasma and cerebrospinal fluid alphalantichymOtrypsin levels in Alzheimer's disease: correlation with cognitive impairment.Ann Neurol, 2003, 53: 81-90.
[7]. Wen GY, Yang SY, Kaczmarski W, et al. Presence of hydroxysteroid dehydrogenase type 10 in amyloid plaques(APs) of Hsiao's APP-Sw transgenic mouse brains. But absence in Aps of Alzheimer's disease brains .Brain Res. 2002. 954:115-122.
[8]. Lee MS, Kao SC, lemere CA, et al. APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol 2003; 163(1): 83-95
[9]. Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging, 2000, 21(3): 383-421
[10]. McGeer PL, Schulzer M, McGeer EG. Arthritis and anti-inflammatory agents are possible protective factors for Alzheimer's disease, a review of 17 epideiologic studies.. Neurology, 1996,47:425-432.
[11]. Hashimoto M, Rockenstein E, Crews L, et al. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and arkinson' s diseases.. NeuromolMed, 2003; 4 (122): 21-36
[12]. Behl C, Davis JB, Lesley R, et al. Hydrogen peroxide mediates amyloidβ protein toxicity. Cell, 1994,77: 817-827.
[13].Hensley K, Carney J, Mattson M, et al. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci, 1994, 91 (8): 3270-3274.
[14]. Lovell MA, Xie C, Markesbery W R.Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimers disease. Neurology, 1998,51:1562-1566.
[15]. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science 2002; 298(5594):789-91
[16].Mayo JC,Sainz RM,Antolin I,et al.Ultrastruall confirmation of neuronal protection by melatonin against the neurotoxin 6-hydroxydopamine cell damage.Brain Res,1999,818(2):22-27.
[17].Perkins CL,Fang G,Kim CN,et al.The role of Apat-1,caspase-9 and Bid protein in etoposide or paclilaxel in-duecd mitochondrial events during apoptosis.Cancer Res,2000,60(6):1645-1653.
[18]Farr SA,Poon HF,Dogrukol-AK D,et al.The antioxidants alphalipoic acid and N-acetylcysteine revelse memory impairment and oxidative stressing in aged SAMP8 mice.J Neurochem,2003,84(5):1173-1183.
[19]Veerendra Kumar MH,Gupta YK.Effect centella assiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats.Clin Exp Pharmacol Physiol,2003,30(5-6):336-342.
[20]Meeocci P.Oxidative stress in mild cognitive impairment and Alzheimer disease:a continuum.J AlzheinmmDis,2004,6(2):159-163.
[21].Nalbamoglu J,Timdo-santago G.Labsaini A,et at.Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein..Nature,1997.387(6632)-500-805
[22].Vina J,Lloret A,Orti R,et al.Molecular bases of the treatment of Alzheimer's disease with antioxidants:prevention of oxidative stress.Mol Aspects Med,2004,25:117-123.
[23]Xiao Aiwu,Dai Jiapei.Axonal Leakage is a Key Neuropathological Change in Alzheimer's disease.Acta Med Univ Sci Technol Huazhong,Apr.2006,vol.35 No.2P277
[24].Walker LC,Kitt CA,Schwam E,et al.Senile plaques in aged squirrel monkeys.Neurobiol Aging.1987,8:291-296
[25].洪岸,姚志彬,顾耀铭,等.老年大鼠学习记忆减退与海马结构的突触素改变,解剖学报,1996,27:164
[26]KumarVB,Vyes K,Frarcko M.Molecular cloning expression and regulation of hippocampal amyboid precursur protein of senescence accelerated mouse(SAMP8).Biocheus Cell Biol,2001;79(1):57-67
[27].Pavia J,AlberchJ,Alvarez I,Toledano A,de Ceballos ML.Repeated administration of beta-amyboid(25-35)to rats decreases muscarinic receptor in cerebral cortex.Neurosci Lett,2000;278(1-2):69-72
[28].Ben Ari Y,Trembley E,Ollergen OP.The role of epileptic activity in hippocampal and remove cerebral lesions induced by bainic acid.Brain Res,1980;(9):79-83
[29].Solroniew MV,Pearson RCA.Degene relation of cholinergic neurone in the basal nuclear fallowing bainic or N-melhyl-D-aspirlic acid application to the cerebral cortex in the rat.Protein Res,1985;339(1):18-19
[30]赵淑梅,左凤英.呆聪液对老龄大鼠痴呆模型免疫功能的影响.淮坊医学院学报,2000;22(1):11-2
[31]张世仪,何利明,张敏磊,等。一种脑损伤所致认知障碍的动物模型。中国康复医学杂志,1993,8(5):196-198
[32]Shang YZ,Cheng JJ,Qi JM,et al.Scutellaria flavonoid reduced memory dysfunction and neuronal injury caused by permanent global ischemia in rats.Pharmacol Biochem & Behav,2005,82:67.
[33]De La.Torry JC.Critically attained threshold of cerebral hypopeffusion:Can it cause Alzheimer's disease.Neurobiol Aging,2000;21(2):32-42
[34]Pappolla MA,Chyan YJ,Poeggeler B.An assessment of the antioxidant and the antiamyloidugenic properties of melatonin:implications for Alzheimer's disease.Neural Transm,2000;107(1):23-31
[35].宋敏,唐军,李达兵,徐海伟,白云,PS1/APP双转基因阿尔茨海默病模型传代小鼠的基因型鉴定及其组织学分析,第三军医大学学报,2006;28(14):1453-1456
[36].Golz J,Probst A,Spillantini MG,et al.Somunto dendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform.EMBO J,1995,14(7)1304-1313
[37].Holtzman DM,Fagan AM,Mackey B,et al.Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.Ann Neurol,2000,47(6):739-74
[38].Van den,Haute C.Spittaels K.Van Dorpe J.et al.Coexpression of human cdk5and its activator p35 with human protein tau in neurons in brain ot triple transgenic mouse.Neurobiol Dis.2001,8:32-34.
[39].Brion JP,Anderton BH,Authelet M,et al.Neurofibrillary tangles and tau phosphorylatlon.Biochem Soc Symp,2001,67:203-210.
[40].Lewis J,Dickson DW,Lin WL,et al.Enhanced Neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.Science,2001.293:148-149
[41].Oddo S,Caccamo A,Kitazawa M,et al.Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.Neurobiol Agin.2003,24:1063-1070.
[42].Iwata N,Tsubuki S,Takaki Y,et al.Metabolic regulation of brain A beta by neprilysin.Science,2001,292:1550-1552
[43].Morimoto K,Yoshimi K,Tonohiro T,et al.The Co-injection of β-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons.Neuroscience,1998,84(2):479.
[44].Nakagawa Y,Nakamura R,Kase K,et al.Colchicine lesions in the rat hippocampus mimic the alterations of several markers in Alzheimer's disease.Brain Res,1987;408(1～2):57-64
[45].Katzmon R.Alzheimer's disease.N Eng J Med,1986,314:964.
[46]李斌,郭德玉,李林.三种老年痴呆动物模型行为学比较.中国实验动物学报,1999,(7):1.
[47].徐海伟,黎海蒂,范晓棠等,AD大鼠模型的制备及行为学和超微结构研究,中国行为医学科学2003,12(2):123-126
[48].王建枝,龚成新,Inge GRUND KE-IQBAL,Khalid IQBAL,Dissociantion of Alzheimer Paired Helical Filaments by Protein Phosphatases.Chinese Journal of Biochemistry and Molecular Biology.Feb,1999,115(1):123-127